Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | F2RL3 | Q96RI0 | 4/20 | 0.36 |
| ▸ | BUB1 | O43683 | 7/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11953198 | 0.86 | S1PR1 (0.38) | DYRK1AMAPT | |
| SCHEMBL1665866 | 0.85 | BUB1 (0.34) | CYP17A1BUB1 | |
| SCHEMBL11953200 | 0.85 | DYRK1A (0.38) | F2RL3DYRK1AMAPT | |
| SCHEMBL11953196 | 0.78 | LATS1 (0.36) | MAPT | |
| SCHEMBL10249232 | 0.76 | BUB1 (0.39) | CYP17A1BUB1MAPTGSK3B | |
| SCHEMBL11953197 | 0.76 | DYRK1A (0.38) | DYRK1A | |
| SCHEMBL11953203 | 0.76 | LMNA (0.32) | DYRK1AMAPT | |
| SCHEMBL4544554 | 0.76 | SGMS2 (0.39) | CYP17A1BUB1MAPTGSK3B | |
| SCHEMBL11953202 | 0.74 | CCR1 (0.32) | DYRK1AMAPT | |
| SCHEMBL16803713 | 0.74 | DYRK1A (0.33) | DYRK1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8742112-B2 | Heterocyclic compound and its use for control of an arthropod pest | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-06-03 | — | — | US | disclosed |
| US-20120196891-A1 | HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120196891-A1 | HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST | HAAO, DDT, ACHE | CYP17A1 459/4885F2RL3 2880/4885BUB1 3350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.